540 Chemie und zugeordnete Wissenschaften
Refine
Has Fulltext
- yes (26)
Is part of the Bibliography
- yes (26)
Year of publication
- 2018 (26) (remove)
Document Type
- Doctoral Thesis (22)
- Journal article (3)
- Preprint (1)
Keywords
- Polymere (3)
- Arzneimittelforschung (2)
- Bor (2)
- 3D powder printing (1)
- Achillea Fragrantissima (1)
- Activation (1)
- Alkamiden (1)
- Alkamides (1)
- Aluminiumnitrid (1)
- Antibiotic (1)
Institute
- Institut für Pharmazie und Lebensmittelchemie (8)
- Institut für Anorganische Chemie (7)
- Institut für Funktionsmaterialien und Biofabrikation (4)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (2)
- Institut für Organische Chemie (2)
- Institut für Physikalische und Theoretische Chemie (2)
- Fakultät für Chemie und Pharmazie (1)
- Graduate School of Science and Technology (1)
- Physikalisches Institut (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 682586 (1)
To understand basic principles about the interaction of electromagnetic radiation with matter is often a challenge in chemical education due to the difficult theoretical background of this topic. The present contribution therefore offers an experimental based introduction into the basic principles of UV/Vis spectroscopy following a three-step strategy. The starting point is to construct a simple self-built spectrometer working within the visible range of light. Learners can explore the most important components of such a device and understand their functions without previous knowledge. In a second step, emission spectra of different common light sources are investigated and compared. Finally, spectroscopic experiments are suggested for chemical education such as the qualitative detection of cations and the quantitative analysis of the dye carmine in food. This context-based introduction links chemical applications with the everyday life. It can be presumed that this way, learners are provided an easier access to radiation-matter interaction.
In resent years the rate of biologics (proteins, cytokines and growth-factors) as newly registered drugs has steadily risen. The greatest challenge for pharmaceutical biologics poses its arrival at the desired target location due to e.g. proteolytic and pH dependent degradation, plasma protein binding, insolubility etc. Therefore, advanced drug delivery systems, where biologics are site directed immobilized to carriers mimicking endogenous storage sites such as the extra cellular matrix can enormously assist the application and consequently the release of exogenous administered pharmaceutical biologics. We have resorted to the fibroblast growth factor 2/ heparansulfate/ fibroblast growth factor bindingprotein 1 system as a model.
Phase I deals with the selection and subcloning of a wild type murine FGF-2 construct into the bacterial pHis-Trx vector system for high yields of expression and fast, feasible purification measurements. This first step enables the provision of mFGF-2, which plays a pivotal part as a growth factor in the wound healing process as well as the vascularization of tumors, for future investigations. Therefore, the correct expression of mFGF-2 was monitored via MALDI-MS and SDS-PAGE, whereas the proper folding of the tertiary beta-trefoil structure was assessed by fluorescence spectroscopy. The MTT assay allowed us to ensure that the bioactivity was comparable to sourced FGF-2. In the last step, the purity; a requirement for future binding- and protein-protein interaction assays was monitored chromatographically (RP-HPLC). In addition, a formulation for freeze-drying was developed to ensure protein stability and integrity over a period of 60 days. Altogether, the bacterial expression and purification proved to be suitable, leading to bioactive and stable production of mFGF-2.
In Phase II the expression, purification and characterization of FGFBP1, as the other key partner in the FGF-2/ HS/ FGFBP1 system is detailed. As FGFBP1 exhibits a complex tertiary structure, comprised of five highly conserved disulfide bonds and presumably multiple glycosylation sites, a eukaryotic expression was used. Human embryonic kidney cells (HEK 293F) as suspension cells were transiently transfected with DNA-PEI complexes, leading to expression of Fc-tagged murine FGFBP1. Different PEI to DNA ratios and expression durations were investigated for optimal expression yields, which were confirmed by western blot analysis and SDS-PAGE. LC-MS/MS analysis of trypsin and elastase digested FGFBP1 gave first insights of the three O-glycosylation sites. Furthermore, the binding protein was modified by inserting a His6-tag between the Fc-tag (for purification) and the binding protein itself to enable later complexation with radioactive 99mTc as radio ligand to track bio distribution of administered FGFBP1 in mice. Overall, expression, purification and characterization of mFGFBP1 variants were successful with a minor draw back of instability of the tag free binding protein.
Combining the insights and results of expressed FGF-2 as well as FGFBP1 directed us to the investigation of the interaction of each partner in the FGF-2/ HS/ FGFBP1 system as Phase III. Thermodynamic behavior of FGF-2 and low molecular weight heparin (enoxaparin), as a surrogate for HS, under physiological conditions (pH 7.4) and pathophysiological conditions, similar to hypoxic, tumorous conditions (acidic pH) were monitored by means of isothermal titration calorimetry. Buffer types, as well as the pH influences binding parameters such as stoichiometry (n), enthalpy (ΔH) and to some extent the dissociation constant (KD). These findings paved the way for kinetic binding investigations, which were performed by surface plasmon resonance assays. For the first time the KD of full length FGFBP1 and FGF-2 was measured. Furthermore the binding behavior of FGF-2 to FGFBP1 in the presence of various heparin concentrations suggest a kinetic driven release of bound FGF-2 by its chaperone FGFBP1.
Having gathered multiple data on the FGF-2 /HS /FGFBP1 system mainly in solution, our next step in Phase IV was the development of a test system for immobilized proteins. With the necessity to better understand and monitor the cellular effects of immobilized growth factors, we decorated glass slides in a site-specific manner with an RGD-peptide for adhesion of cells and via the copper(I)-catalyzed-azide-alkyne cycloaddition (CuAAC) a fluorescent dye (a precursor for modified proteins for click chemistry). Human osteosarcoma cells were able to grow an the slides and the fluorescence dye was immobilized in a biocompatible way allowing future thorough bioactivity assay such as MTT-assays and phospho-ERK-assays of immobilized growth factors.
Bioorthogonal funktionalisierte Sphingolipide zur Evaluierung von Lipiddynamiken \(in\) \(vivo\)
(2018)
In der Kontrolle von viralen oder bakteriellen Infektionen spielen Sphingolipide eine essentielle Rolle[335-336], weshalb sich inzwischen die Forschung vermehrt an Sphingolipiden und -analoga als Wirkstoffen gegen die verschiedensten Erreger beschäftigt.[9] Dabei finden in der Synthese und Identifikation potentieller Wirkstoffe auch clickchemiebasierte Ansätze Anwendung.[224] Allerdings ist die Wirkweise von sphingolipidbasierten Pharmaka auch in viraler und mikrobieller Pathogenese bisher ungeklärt.
Mit der Entdeckung der CuAAC[112-113] sowie deren modernen Varianten und Alternativen, die gemeinsam unter dem Begriff Clickchemie zusammengefasst werden, ist es möglich, die strukturellen Änderungen von Biomolekülen klein zu halten und durch spätere Konjugation mit Farbstoffen Fluoreszenspektroskopie zu ermöglichen.[339-340] Während in den letzten Jahren die Clickchemie breite Anwendung zur Modifikation von Proteinen[130], Kohlenhydraten[341] und DNA[340] gefunden hat blieben Lipide lange unbeachtet[342], was vor allem auch für Sphingolipide gilt.
In dieser Arbeit werden bioorthogonal funktionalisierte Sphingolipide und -analoga vorgestellt, um die Vielseitigkeit der Clickchemie auf das Feld der Sphingolipide zu übertragen. Die clickfähigen Lipidanaloga ermöglichen detaillierte Einblicke in die dynamische Organisation von Sphingolipiden bei Infektionsprozessen und ihr Einsatz als therapeutische Wirkstoffe oder zur Generierung von antibakteriellen Oberflächenbeschichtungen wurden untersucht.
Die dargestellten azidmodifizierten Sphingolipide und –analoga konnten in Zusammenarbeit mit Kooperationspartnern, bezüglich ihrer Verwendung in Visualisierungsexperimenten und antibakteriellen Eigenschaften untersucht werden.
Die Ceramidderivate konnten genutzt werden, um den Einfluss von Kettenlänge und Position des Azides der acylierten Säure auf die in vivo-Konjugation mit dem Fluoreszenzfarbstoff DBCO-Sulfo-Cy5 in Jurkatzellen genauer zu untersuchen.[211]
Auch konnten azidfunktionalisierte Ceramide auf ihre Eignung zur Visualisierung von Ceramiddynamiken während T-Stimulation untersucht werden.[205] In diesem Zusammenhang sind visualisierbare Ceramide von besonderer Bedeutung, da die T-Zellstimulation die ASM-Aktivierung zur Folge hat, die wiederum Ceramide freisetzt.
Mit dem azidmodifizierten Phytosphingosinderivat gelang es erstmals ein azidmodifiziertes Sphingolipid nach Inkubation von Arabidopsis thaliana Setzlingen mittels CuAAC mit einem Fluoreszenzfarbstoff zu konjugieren.[258]
Des Weiteren konnten die azidfunktionalisierten N-Oleoylserinole in verschiedenen Zelltypten erfolgreich eingebaut und selektiv mit Fluoreszenzfarbstoff visualisiert werden. Kofärbungen mit GFP-PKCζ und Antikörpermarkierungen von Ceramid sowie PKCζ zeigten, dass es sich bei den Enantiomeren um ceramidimitierende Lipidanaloga handelt. Somit eignen sich diese N-Oleoylserinolanaloga, um die Interaktion von Ceramiden mit der Proteinkinase Cζ zu untersuchen.
Da viele natürliche Sphingolipide antibakterielle Eigenschaften aufweisen, konnte in Kooperation mit Jérôme Becam der Einsatz azidmodifizierter Ceramide als Wirkstoff gegen Neisseria meningitidis, Neisseria gonorrhoeae sowie Escherichia coli und Staphylococcus aureus untersucht werden. ωN3-C6-Cer zeigt gute bakterizide Eigenschaften gegen Neisseria meningitidis und Neisseria gonorrhoeae, ohne dabei toxisch gegenüber den Wirtszellen zu sein. Die Ceramidanaloga αN3-C6-Cer, αN3-C16-Cer und ωN3-C16-Cer weisen keine antibakteriellen Eigenschaften auf, aber sie wurden effizient in die Membran der Neisseriae eingebaut und konnten ebenfalls erfolgreich bioorthogonal markiert werden. Des Weiteren zeigten hochauflösende dSTORM-Aufnahmen der Bakterien, im Gegensatz zu Humanzellen, eine homologe Verteilung der konjugierten Ceramide. Da Ceramide eine wichtige Rolle in der Infektionsbekämpfung spielen, sind die in dieser Arbeit synthetisierten azidmodifizierten Ceramide wertvolle Werkzeuge, um die Interaktion von Bakterien mit Humanzellen zu untersuchen.
Außerdem konnte im Rahmen dieser Arbeit erfolgreich eine innovative Methode entwickelt werden, um alkinpräsentierende Linker auf die Oberfläche von Nunc Covalink 96 Microtiterplatten kovalent zu binden und die Alkine konnten anschließend mittels CuAAC mit den in dieser Arbeit synthetisierten azidfunktionalisierten Lipiden zu konjugiert werden. Ziel der Methode war es potentielle Moleküle für bakterizide Oberflächenmodifikationen zu identifizieren. Mittels solcher Oberflächenmodifikationen soll die Biofilmbildung in Endotrachealtuben verhindert, und damit die Entstehung von beatmungsassozierten Pneumonien unterbunden werden. Die lipidmodifizierten Microtiterplatten sollen zukünftig auch genutzt werden, um sphingolpidaffine Proteine aus Zelllysaten zu identifizieren.
Progressive loss of skeletal muscle mass, strength and function poses a major threat to independence and quality of life, particularly in the elderly. To date, sarcopenia therapy consists of resistance exercise training in combination with protein supplementation due to the limited efficacy of available pharmacological options in counteracting the effects of muscle wasting. Therapeutic intervention with growth factors including insulin-like growth factor I (IGF-I) or inhibitors of myostatin a potent suppressor of myogenesis hold potential to rebalance the altered activity of anabolic and catabolic cytokines. However, dosing limitations due to acute side effects and disruptions of the homeostasis have so far precluded clinical application.
Intending to provide a therapy with a superior safety and efficacy profile by directing drug release to inflamed tissue and minimizing off-target activity, we designed bioresponsive delivery systems for an anti-catabolic peptide and anabolic IGF-I responding to local flares of muscle wasting.
In Chapter I, current concepts for bioorthogonal conjugation methods are discussed and evaluated based on various drug delivery applications. With a focus on protein delivery, challenges and potential pitfalls of each chemical and enzymatic conjugation strategy are analyzed and opportunities regarding their use for coupling of biomolecules are given. Based on various studies conjugating proteins to polymers, particles and biomaterials using different site-directed approaches, the chapter summarizes available strategies and highlights certain aspects requiring particular consideration when applied to biomolecules. Finally, a decision process for selection of an optimum conjugation strategy is exemplarily presented.
Three of these bioorthogonal coupling reactions are applied in Chapter II detailing the potential of site-directed conjugation in the development of novel, homogenous drug delivery systems. The chapter describes the design of a delivery system of a myostatin inhibitor (MI) for controlled and local release counteracting myositis flares. MI release from the carrier is driven by increased matrix metalloproteinase (MMP) levels in compromised muscle tissues cleaving the interposed linker, thereby releasing the peptide inhibitor from the particulate carrier. Release experiments were performed to assess the response towards various MMP isoforms (MMP-1, -8, -9 and -13) – as upregulated during skeletal muscle myopathies – and the release pattern of the MI in case of disease progression was analyzed. By selection of the protease-sensitive linker (PSL) showing variable susceptibilities to proteases, release rates of the MI can be controlled and adapted. Immobilized MI as well as released MI as response to MMP upregulation was able to antagonize the effects of myostatin on cell signalling and myoblast differentiation.
The approach of designing bioresponsive protein delivery systems was also applied to the anabolic growth factor IGF-I, as described in Chapter III. Numerous studies of PEGylated proteins or peptides reveal, that successful therapy is challenged by safety and efficacy issues, as polymer attachment considerably alters the properties of the biologic, thereby jeopardizing clinical efficacy. To this end, a novel promising approach is presented, intending to exploit beneficial effects of PEGylation on pharmacokinetics, but addressing the pharmacodynamic challenges by releasing the protein upon entering the target tissue. This was realized by integration of a PSL between the PEG moiety and the protein. The soluble polymer conjugate was produced by site-directed, enzymatic conjugation of IGF-I to the PSL, followed by attachment of a 30 kDa-PEG using Strain-promoted azide-alkyne cycloaddition (SPAAC). This strategy illustrates the potential of bioorthogonal conjugation (as described in Chapter I) for generation of homogenous protein-polymer conjugates with reproducible outcome, but also emphasizes the altered protein properties resulting from permanent polymer conjugation. As compared to wild type IGF-I, the PEGylated protein showed considerable changes in pharmacologic effects – such as impaired insulin-like growth factor binding protein (IGFBPs) interactions, submaximal proliferative activity and altered endocytosis patterns. In contrast, IGF-I characteristics were fully restored upon local disintegration of the conjugate triggered by MMP upregulation and release of the natural growth factor.
For successful formulation development for the proteins and conjugates, the careful selection of suitable excipients is crucial for a safe and reliable therapy. Chapter IV addresses one aspect by highlighting the chemical heterogeneity of excipients and associated differences in performance. Polysorbate 80 (PS80) is a surfactant frequently used in protein formulations to prevent aggregation and surface adsorption. Despite being widely deployed as a standard excipient, heterogeneous composition and performance entails the risk of eliciting degradation and adverse effects on protein stability. Based on a comprehensive study using different batches of various suppliers, the PS80 products were characterized regarding chemical composition and physicochemical properties, facilitating the assessment of excipient performance in a formulation. Noticeable deviations were recorded between different suppliers as well as between batches of the same suppliers. Correlation of all parameters revealed, that functionality related characteristics (FRCs) could be reliably predicted based on chemical composition alone or by a combination of chemical and physicochemical properties, respectively.
In summary, this thesis describes and evaluates novel strategies for the targeted delivery and controlled release of biologics intended to counteract the imbalance of anabolic and catabolic proteins observed during aging and musculoskeletal diseases. Two delivery platforms were developed and characterized in vitro – (i) using anti-catabolic peptides immobilized on a carrier for local delivery and (ii) using soluble IGF-I polymer conjugates for systemic application. Both approaches were implemented by bioorthogonal coupling strategies, which were carefully selected in consideration of limitations, side reactions and efficiency aspects. Bioresponsive release of the active biomolecules following increased protease activity could be successfully realized. The therapeutic potential of these approaches was demonstrated using various cell-based potency assays. The systems allow targeted and controlled release of the growth factor IGF-I and anti-catabolic peptides thereby overcoming safety concerns of current growth factor therapy and thus positively impacting the benefit-risk profile of potent therapeutics. Taking potential heterogeneity and by-product concerns into account, comprehensive excipient characterization was performed and a predictive algorithm for FRCs developed, in order to facilitate formulation design and guarantee a safe and efficient therapy from start to finish.
Coherent two-dimensional (2D) optical spectroscopy has revolutionized our ability to probe many types of couplings and ultrafast dynamics in complex quantum systems. The dynamics and function of any quantum system strongly depend on couplings to the environment. Thus, studying coherent interactions for different environments remains a topic of tremendous interest. Here we introduce coherent 2D electronic mass spectrometry that allows 2D measurements on effusive molecular beams and thus on quantum systems with minimum system-bath interaction and employ this to identify the major ionization pathway of 3d Rydberg states in NO2. Furthermore, we present 2D spectra of multiphoton ionization, disclosing distinct differences in the nonlinear response functions leading to the ionization products. We also realize the equivalent of spectrally resolved transient-absorption measurements without the necessity for acquiring weak absorption changes. Using time-of-flight detection introduces cations as an observable, enabling the 2D spectroscopic study on isolated systems of photophysical and photochemical reactions.
Several transition metal ions, like Fe2+, Co2+, Ni2+, and Zn2+ complex to the ditopic ligand 1,4-bis(2,2’:6’,2’’-terpyridin-4’-yl)benzene. Due to the high association constant, metal ion induced self-assembly of Fe2+, Co2+, and Ni2+ leads to extended, rigid-rod like metallo-supramolecular coordination polyelectrolytes (MEPEs) even in aqueous solution. Here, the kinetics of coordination and the kinetics of growth of MEPEs are presented. The species in solutions are analyzed by stopped-flow fluorescence spectroscopy, light scattering, viscometry and cryogenic transmission electron microscopy. At near-stoichiometric amounts of the reactants, high molar masses are obtained, which follow the order Ni-MEPE ~ Co-MEPE < Fe-MEPE. Furthermore, a way is presented to adjust the average molar mass, chain-length and viscosity of MEPEs using the monotopic chain stopper 4’-(phenyl)-2,2’:6’,2’’-terpyridine.
The present thesis comprises synthesis and stoichiometric model reactions of well-defined NHC-stabilized copper(I) complexes (NHC = N-heterocyclic carbene) in order to understand their basic reactivity in borylation and cross-coupling reactions. This also includes the investigations of the reactivity of the ligands used (NHCs and CaaCs = cyclic alkyl(amino)carbenes) with the substrates, i.e. diboron(4) esters and arylboronates, which are addressed in the second part of the thesis.
Diese Arbeit beschäftigt sich mit der Synthese, Reaktivität und den physikalischen Eigenschaften verschiedener Cyanoborate. Es gelang die optimierte Synthese des Tricyanofluoroborates M[BF(CN)3] (M = Na, K) mittels Lewis-Säure-Katalyse. Aus diesem Borat wurde mittels Reduktion das Bor-zentrierte Nukleophil B(CN)3 2− hergestellt, welches ebenfalls über die äußerst ungewöhnliche Depronotierung des [BH(CN)3]− -Anions zugänglich ist. Das B(CN)3 2− -Dianion wurde erfolgreich mit diversen Elektrophilen wie z.B. Alkylhalogeniden, CO2, CN+-Quellen sowie per- und teilfluorierten Aromaten umgesetzt. Darüber hinaus ergibt die Synthese mit Tricyanohalogenoborat-Anionen das ungewöhnlich stabile gekoppelte Diborat-Dianion [B2(CN)6]2−, welches über einen SN2-Mechanismus entsteht und eine elektronenpräzise B-B-Bindung aufweist. Ferner wurden Ionische Flüssigkeiten mit Perfluoraklylcyanoboraten hergestellt und die physikalischen Parameter systematisch und ausführlich untersucht.
A major problem regarding public health is the emergence of antibiotic resistant bacterial strains, especially methicillin resistant Staphylococcus aureus (MRSA). This is mainly attributed to the unnecessary overuse of antimicrobial drugs by patients; however, one aspect that is often neglected is their untargeted mechanism of action, affecting not only the infection itself but also commensal bacteria which are often opportunistic pathogens causing many diseases as well. Therefore, our goal was to develop a bioresponsive antibiotic delivery system triggered by virulence factors. The designed system is comprised of a polymer to enhance its pharmacokinetic profile, a peptide cleavable linker, and the antibiotic agent itself. The bacterial protease aureolysin which is expressed by S. aureus during infections would cleave the linker and partially release the antibiotic which would be still attached to a remaining tetrapeptide. These would be cleaved by a group of proteases naturally present in plasma called aminopeptidases, finally releasing the compound.
In the first part of this project, we searched for a suitable sequence to serve as a cleavable linker. It should be sensitive towards the target bacterial protease but not be cleaved by any human enzymes to guarantee the specificity of the system. Therefore, we synthesized three peptide sequences via Solid Phase Peptide Synthesis and incubated them with aureolysin as well as with many human matrix Metalloproteases. The analysis and quantification of enzymatic activity was monitored chromatographically (RP-HPLC). The plasminogen originated sequence was chosen since it was not sensitive towards MMPs, but cleaved by aureolysin.
In the second part, we tried to incorporate the chosen peptide sequences as crosslinkers in hydrogel formulations. The purpose was to physically incorporate the antibiotic within the hydrogel, which would be released by the cleavage of those sequences and the consequent loosening the hydrogel net. For that purpose we used a commercially available hydrogel kit with a PVA matrix modified with maleimide, which allows a conjugation reaction with thiol functionalized crosslinkers. Three fluorophores were chosen to serve as antibiotic models and a diffusion assay was performed. Only the glomerular structured Green Fluorescent Protein (GFP) presented a low diffusion rate, thus the aureolysin release assays were performed only using this prototype. Assays showed that with a low hydrogel polymer concentration, the fluorophore either quickly diffused into the medium or was not released at all. The physical incorporation of the antibiotic within the hydrogel pores was therefore abolished as a suitable release approach. For a second attempt, we covalently bound a fluorophore to the linker, which was conjugated to the hydrogel matrix. The incubation with aureolysin and subsequent RP-HPLC analysis showed a peak with the same retention time correspondent to the fragment product after cleavage of the free linker. This is a proof that the concept of linking the peptide sequence to the antibiotic is a promising strategy for its bioresponsive release.
Within the third part of this study, we analyzed the degradation of the resulted fragment after aureolysin activity and subsequent full release of the antibiotic by human aminopeptidases. We determined the concentration of those enzymes in human plasma and synthesized the fragment by conjugating the tetrapeptide sequence to aminofluorescein via EDC/NHS reaction. By incubating the construct with the lowest aminopeptidase concentration measured in plasma, the fluorophore was completely released within two hours, showing the efficacy of these enzymes as bioresponsive agents.
The last part was the construction of the PEGylated linker-antibiotic. For this purpose we chose the tetracycline like antibiotic chelocardin (CHD) as our prototype. The conjugation of the linker- CHD to the polymer was performed by copper free click chemistry. The cleavage rate of the linker by aureolysin was very similar to the one obtained for the free peptide, indicating that the PEGylation does not interfere on the enzymatic activity. However, by trying to increase the loading ratio of chelocardin onto the polymer, we observed a very low cleavage rate for the system, indicating the formation of aggregates by those constructs.
The designed system has proved to be a smart strategy for the delivery on demand of antibiotics in which the drug is only released by the presence of S. aureus during their virulent state.